Learning objectives and who should attend

Why attend

  • To gain insight into cutting-edge immunoprevention research that could redefine ovarian cancer prevention.
  • To understand how epitope mapping, immune memory and mRNA vaccine design can be applied in gynaecological oncology.
  • To engage directly with internationally recognised experts translating benchside discoveries into potential clinical applications.
  • To stay ahead of evolving trends in preventive oncology and personalised medicine relevant to women’s health. 

Who should attend

  • All clinicians in obstetrics and gynaecology
  • Academics (including academic doctors/clinicians) 
  • Allied health professionals
  • GPs
  • Health policy makers
  • Midwives
  • Nurses
  • Physician Associates
  • Students

Disclaimer: RCOG is not responsible for the content of any non-RCOG website linked from this page. Cookies: Links within this page may lead to the RCOG website which uses cookies for a number of reasons. Read the RCOG Privacy Policy and Data Protection Policy. Limitations of use: Under no circumstances shall RCOG be liable for any special or consequential damages arising from the use or reliance on information contained within this page.